Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 212 participants.
Also called NCT07243080
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 212 participants
- Registry
-
NCT07243080
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Recruiting
Technical summary
Registry record NCT07243080. Randomized; single masking; primary purpose prevention. Start 2025-10-10 (actual); primary completion 2025-11-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention
- Condition
- Deep Venous Thromboses
- Condition
- Laparotomy Patients
- Intervention (Drug)
- rivaroxaban (10mg)
- Intervention (Drug)
- Enoxaparin 40 mg SC
- Lead sponsor
- Mayo Hospital Lahore
- Collaborator
- King Edward Medical University
Record details
- Record id
cardio:ct-nct07243080- Content hash
79bd315e6ffa7682341443b35beb75c7981b407cb6d082f54dcbaa2b8d6ff545